GLGlobe Life

$154.76+16% 1Y

$154.76

$129.8152 weeks$186.02

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 10.3 vs a 11.5 median over 41 quarters (−11% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)top 10% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Globe Life trades at 10.3× earnings against 14.2× for the median Insurance - Life name, cheaper than its own group.

10.3

Trailing P/E · Insurance - Life median 14.2 · cheaper than the typical name in its group

Details›

What the market has paid for these earnings: 41 quarters of its own multiple × $15.07 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$138.87
Its own P/E history, median	$173.34
Its own P/E history, upper quartile	$197.07
52-week range	$129.81 – $186.01
Today	$154.76

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.

The closest names by size in the same industry